암세포 대사의 이해와 갑상선암

키워드

참고문헌 (42)

1. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, 19(11), pp.1167~1214 (2009)
2. Shoup M, "Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma", J Am Coll Surg, 197(2), pp.191~197 (2003)
3. Schlumberger M, "Definition and management of radioactive iodine-refractory differentiated thyroid cancer", Lancet Diabetes Endocrinol, 2(5), pp.356~358 (2014)
4. Durante C, "Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy", J Clin Endocrinol Metab, 91(8), pp.2892~2899 (2006)
5. Brose MS, "Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial", Lancet, 384(9940), pp.319~328 (2014)
6. Schlumberger M, "Lenvatinib versus placebo in radioiodinerefractory thyroid cancer", N Engl J Med, 372(7), pp.621~630 (2015)
7. Fojo T, "Biologically targeted cancer therapy and marginal benefits: are we making too much of too little or are we achieving too little by giving too much?", Clin Cancer Res, 16(24), pp.5972~5980 (2010)
8. Bock C, "Computational epigenetics", Bioinformatics, 24(1), pp.1~10 (2008)
9. Gillies RJ, "Evolutionary dynamics of carcinogenesis and why targeted therapy does not work", Nat Rev Cancer, 12(7), pp.487~493 (2012)
10. Stincone A, "The return of metabolism: biochemistry and physiology of the pentose phosphate pathway", Biol Rev Camb Philos Soc, 90(3), pp.927~963 (2015)
11. Vander Heiden MG, "Targeting cancer metabolism: a therapeutic window opens", Nat Rev Drug Discov, 10(9), pp.671~684 (2011)
12. Sborov DW, "Investigational cancer drugs targeting cell metabolism in clinical development", Expert Opin Investig Drugs, 24(1), pp.79~94 (2015)
13. Warburg O, "The Metabolism of Tumors in the Body", J Gen Physiol, 8(6), pp.519~530 (1927)
14. Warburg O, "On the origin of cancer cells", Science, 123(3191), pp.309~314 (1956)
15. Warburg O, "On respiratory impairment in cancer cells", Science, 124(3215), pp.269~270 (1956)
16. fluorodeoxyglucose and beyond, "Clin Cancer Res", 2007, 3460~3469
17. Weinhouse S, "The Warburg hypothesis fifty years later", Z Krebsforsch Klin Onkol Cancer Res Clin Oncol, 87(2), pp.115~126 (1976)
18. 장미란, "Cancer cell metabolism: implications for therapeutic targets", Experimental and Molecular Medicine, 45(10), pp.1~8 (2013), 생화학분자생물학회
19. Kroemer G, "Tumor cell metabolism: cancer's Achilles' heel", Cancer Cell, 13(6), pp.472~482 (2008)
20. Pouyssegur J, "Hypoxia signalling in cancer and approaches to enforce tumour regression", Nature, 441(7092), pp.437~443 (2006)
21. Gatenby RA, "Why do cancers have high aerobic glycolysis?", Nat Rev Cancer, 4(11), pp.891~899 (2004)
22. Koukourakis MI, "Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma", Cancer Res, 66(2), pp.632~637 (2006)
23. Swietach P, "Regulation of tumor pH and the role of carbonic anhydrase 9", Cancer Metastasis Rev, 26(2), pp.299~310 (2007)
24. Fischer K, "Inhibitory effect of tumor cell-derived lactic acid on human T cells", Blood, 109(9), pp.3812~3819 (2007)
25. Hensley CT, "Glutamine and cancer: cell biology, physiology, and clinical opportunities", J Clin Invest, 123(9), pp.3678~3684 (2013)
26. Reitzer LJ, "Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells", J Biol Chem, 254(8), pp.2669~2676 (1979)
27. DeBerardinis RJ, "Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis", Proc Natl Acad Sci U S A, 104(49), pp.19345~19350 (2007)
28. Schulze A, "How cancer metabolism is tuned for proliferation and vulnerable to disruption", Nature, 491(7424), pp.364~373 (2012)
29. Cairns RA, "Regulation of cancer cell metabolism", Nat Rev Cancer, 11(2), pp.85~95 (2011)
30. Wise DR, "Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction", Proc Natl Acad Sci U S A, 105(48), pp.18782~18787 (2008)
31. David CJ, "HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer", Nature, 463(7279), pp.364~368 (2010)
32. Matoba S, "p53 regulates mitochondrial respiration", Science, 312(5780), pp.1650~1653 (2006)
33. Bensaad K, "TIGAR, a p53-inducible regulator of glycolysis and apoptosis", Cell, 126(1), pp.107~120 (2006)
34. Li T, "Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence", Cell, 149(6), pp.1269~1283 (2012)
35. Munoz-Pinedo C, "Cancer metabolism:current perspectives and future directions", Cell Death Dis, 3, pp.e248~ (2012)
36. Vicha A, "Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma", Endocr Relat Cancer, 21(3), pp.R261~277 (2014)
37. Tomlinson IP, "Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer", Nat Genet, 30(4), pp.406~410 (2002)
38. Dunn WB, "Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes", Phys Biol, 5(1), pp.011001~ (2008)
39. Armitage EG, "Metabolomics in cancer biomarker discovery: current trends and future perspectives", J Pharm Biomed Anal, 87, pp.1~11 (2014)
40. Patti GJ, "Innovation: Metabolomics: the apogee of the omics trilogy", Nat Rev Mol Cell Biol, 13(4), pp.263~269 (2012)
41. You L, "Application of stable isotope-assisted metabolomics for cell metabolism studies", Metabolites, 4(2), pp.142~165 (2014)
42. Lawrence MS, "Mutational heterogeneity in cancer and the search for new cancer-associated genes", Nature, 499(7457), pp.214~218 (2013)

관련 논문AI추천